Navigation Links
UCF patented on induced pluripotent stem cells, iPS cells
Date:12/22/2011

A process that prompts a single gene to generate millions of supercharged stem cells, which can then turn into any kind of cell a body needs to repair itself, has been patented at the University of Central Florida.

Stem cells have long been regarded as a holy grail of sorts in the medical world, because they hold so much potential for treating and perhaps curing some of the most challenging diseases in our time, such as Alzheimer's,Parkinson's and diabetes.

But a limited supply of stem cells and ethical issues associated with cells from embryonic donors have stalled progress on many fronts. For the past decade, researchers around the world have tried to generate embryonic-like stem cells from adult donors. To achieve stem cells this way, several genes have been required. And many of those genes have been known to trigger cancer. UCF's approach, called Induced pluripotent stem (iPS) cell technology, minimizes the risk because only one gene (Nanog) is used in the process.

A study described in Science noted that the gene, which had not been used by others, is not linked to cancer. The study can be seen at: http://www.sciencemag.org/site/products/lst_20070420.xhtml

"This technology has the potential of literally changing the entire landscape of regenerative medicine," said Kiminobu Sugaya, the lead researcher and a professor at UCF's College of Medicine. "This technology demonstrates the ability to use a patient's own cells for treatment of a wide range of illness, injury or disease."

Sugaya has been investigating the potential use of stem cells in treating Alzheimer's disease for years. He holds dozens of patents including the one for this iPS technology, which was recently licensed to Progenicyte, an emerging biopharmaceutical company Sugaya founded in 2008. Sugaya and Progenicyte will now begin extensive collaborate efforts to advance this new technology from the lab to the treatment of patients.

With better access to stem cells, scientists may be able to open the body's healing power more quickly, giving Alzheimer, Parkinson, diabetes, cancer and heart disease patients hope that their own cells may help them get rid of these diseases, Sugaya said.


'/>"/>
Contact: Zenaida Kotala
zenaida.kotala@ucf.edu
407-823-6120
University of Central Florida
Source:Eurekalert  

Related biology news :

1. Benefits abound with recently patented system that reduces phosphorus in wastewater
2. SRNL demonstrating low-energy remediation with patented microbes
3. Microchip patented which separates and extracts tumor cells in the blood
4. UGA researchers use patented SERS technique to rapidly, accurately detect rotavirus strain
5. New patented technology for improving cardiac CTs receives NIH support
6. Stantum Offering Demo, Evaluation & Development Board Based on Its Patented Resistive Multi-Touch Technology
7. When inflexibility is counterproductive: Mechanism of UV-induced DNA Dewar lesion revealed
8. Addex scientists discover GLP-1 induced interaction between GLP-1 and GIP receptors
9. Cedars-Sinai opens new Induced Pluripotent Stem Cell Core Production Facility
10. Study finds therapies using induced pluripotent stem cells could encounter immune rejection problems
11. Big picture of how interferon-induced genes launch antiviral defenses revealed
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UCF patented on induced pluripotent stem cells, iPS cells
(Date:1/11/2017)... Jan. 11, 2017  Michael Johnson, co-founder of Visikol Inc. a ... Inc., has been named to the elite "Forbes 30 Under 30" ... of 600 people in 20 fields nationwide to be recognized as ... 15,000 applicants were selected. ... He is currently a PhD candidate at Rutgers University. ...
(Date:1/4/2017)... LAS VEGAS , Jan. 4, 2017  For the thousands of ... , a global leader in connected health and biometric measurement devices and ... pressure monitors. On display in A&D Medical,s special CES ... monitors represent the ongoing expansion of the company,s WellnessConnected product ... ...
(Date:12/22/2016)... December 22, 2016 SuperCom (NASDAQ: ... solutions for the e-Government, Public Safety, HealthCare, and Finance sectors announced ... has been selected to implement and deploy a community-based supportive services ... Northern California , further expanding its presence in the state. ... This new program, ...
Breaking Biology News(10 mins):
(Date:1/18/2017)... ... 18, 2017 , ... MYOLYN, which creates medical technology for ... 510(k) to the FDA, requesting clearance of the MyoCycle Home and the MyoCycle ... , The submission marks a major milestone for the technology startup. MYOLYN ...
(Date:1/18/2017)... ... January 18, 2017 , ... uBiome, the leading ... by its Science Editor, Dr. Elisabeth Bik, in the December 2016 issue of ... joined uBiome in October 2016 from her previous position at Stanford University School ...
(Date:1/18/2017)... , Jan. 18, 2017  Caris Life Sciences, ... Lustgarten Foundation, the largest private funder of pancreatic ... trial evaluating the impact of immunotherapy in the ... trial enrollment services to identify potential trial candidates ... between treating physicians and study investigators. The Lustgarten ...
(Date:1/17/2017)... IA (PRWEB) , ... January 17, 2017 , ... ... China for Balance™ GT soybeans. The new Balance™ GT Soybean Performance System will ... glyphosate and isoxaflutole, the active ingredient in the new Balance® Bean herbicide. The ...
Breaking Biology Technology: